Comprehensive Transcriptomic Analysis and Biomarker Prioritization of Hydroxyprogesterone in Breast Cancer.
Ontology highlight
ABSTRACT: Hydroxyprogesterone (HP) is a synthetic progestogen widely used in obstetric care, and its potential influence on breast cancer biology has become an emerging area of interest. Despite its clinical use, the molecular mechanisms by which HP affects tumor tissue remain insufficiently explored. In this study, transcriptomic profiling was performed to investigate gene expression changes associated with HP in operable breast cancer. Pre-operative 17α-HP caproate (17-OHPC) exposure was associated, in normal adjacent tissue (NAT), with activation of steroid-hormone and lipid/xenobiotic-metabolism programs and crosstalk to phosphoinositide 3-kinase (PI3K)-Akt and nuclear factor kappa B (NF-κB). In NAT, these pathways showed the largest absolute log2 fold-change (|log2FC|); si
SUBMITTER: Rafi A
PROVIDER: S-EPMC12839910 | biostudies-literature | 2026 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA